Chitosan Nanoparticle-Based Drug Delivery Systems: Advances, Challenges, and Future Perspectives
Polymers · 23.05.2025 · 17 (11) · 1453
DOI: 10.3390/polym17111453 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Polymers, online erschienen am 23.05.2025. Verfasst von Alina Stefanache und 11 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, "Grigore T. Popa" University of Medicine and Pharmacy, 16 Universității Street, 700115 Iași, Romania. Die Arbeit wurde bisher 116-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The effectiveness and uses of chitosan nanoparticles (CNPs) in drug delivery systems are examined in this work. Important results include the improved drug encapsulating efficiency: CNPs showed up to 90% encapsulation for different therapeutic agents. Furthermore, the research shows that CNPs provide extended-release patterns, greatly enhancing medication bioavailability especially for hydrophobic compounds. One interesting outcome was the greater drug stability in acidic surroundings, which are common in the stomach, where CNPs turn into a gel and later inflate in the intestine where the drug is released. Moreover, CNPs showed a 2–3-fold improvement in the absorption of encapsulated pharmaceuticals relative to traditional formulations, therefore indicating their capacity to overcome the problems of low oral bioavailability. These nanoparticles’ pH-sensitive character produced a 50–70% increase in drug release at certain pH values, hence maximizing therapeutic results. Significantly less systemic toxicity was seen in the in vivo tests, and at therapeutic dosages there were no noted side effects. Histological study confirmed the biocompatibility and non-toxicity of CNPs, therefore attesting their fit for long-term usage. These results highlight the great potential of CNPs in providing effective, focused, continuous drug release, hence improving therapeutic effectiveness and patient compliance.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Pharmacy, "Grigore T. Popa" University of Medicine and Pharmacy, 16 Universității Street, 700115 Iași, Romania.
- Faculty of General Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, 16 Universității Street, 700115 Iași, Romania.
- Faculty of Medicine and Pharmacy, "Dunărea de Jos" University Galaţi, Domneasca Street, Nr. 47, 800008 Galați, Romania.
ORCID-Profile: Ionut Iulian Lungu, Nicoleta Anton, Cristian Gutu, Alina Plesea Condratovici, Madalina Duceac Covrig, Letitia Doina Duceac, Monica Boev
Zitieren
APA
Stefanache, A., Lungu, I. I., Anton, N., Damir, D., Gutu, C., Olaru, I., Plesea Condratovici, A., Duceac Covrig, M., Constantin, M., Calin, G., Duceac, L. D., & Boev, M. (2025). Chitosan Nanoparticle-Based Drug Delivery Systems: Advances, Challenges, and Future Perspectives. Polymers, 17(11), 1453. https://doi.org/10.3390/polym17111453
Vancouver
Stefanache A, Lungu II, Anton N, Damir D, Gutu C, Olaru I, et al. Chitosan Nanoparticle-Based Drug Delivery Systems: Advances, Challenges, and Future Perspectives. Polymers. 2025;17(11):1453. doi:10.3390/polym17111453
BibTeX
@article{Stefanache2025,
author = {Stefanache, Alina and Lungu, Ionut Iulian and Anton, Nicoleta and Damir, Daniela and Gutu, Cristian and Olaru, Iulia and Plesea Condratovici, Alina and Duceac Covrig, Madalina and Constantin, Marcu and Calin, Gabriela and Duceac, Letitia Doina and Boev, Monica},
title = {Chitosan Nanoparticle-Based Drug Delivery Systems: Advances, Challenges, and Future Perspectives},
journal = {Polymers},
year = {2025},
volume = {17},
number = {11},
pages = {1453},
doi = {10.3390/polym17111453}
}
EUVIMED